Back to Agendas
New Pandemics: Lessons Learned from the Ebola Experience
Session Chair(s)
Diane Berry, PhD
Vice President, Global Health Policy and Government Affairs
Sarepta Therapeutics, United States
Pandemics pop up periodically; as regulators and innovators, we try to quash them as quickly as we can. Ebola has been a frightening experience and demonstrates the speed at which a disease, previously contained by remoteness, can spread and cause panicked public reactions. On the regulatory, funding and preparedness fronts, this forum will help elucidate what we learned from 2014's Ebola outbreak, and how agencies and public health organizations are preparing for the next global challenge. We will hear some “war stories” about the challenges of coordinating a global response and the difficulties of coordinating across agencies in exigent circumstances and hear ideas of how to avoid these problems in the future.
Learning Objective : Describe novel strategies regulators used to try to address the Ebola crisis; Discuss how agencies and public health organizations will work together to address new pandemics and collaborate on strategy.
Speaker(s)
FDA Point of View
Luciana Borio, MD
In-Q-Tel, United States
Vice President, Technical Staff
Industry Point of View
Mark Feinberg, MD, PhD
International AIDS Vaccine Initiative, United States
President and Chief Executive Officer
New Pandemics: Regulatory Challenges
Kerstin Adolph, DrSc
Clinlogix LLC, Germany
Senior Clinical Project Manager
Have an account?